The approval of lecanemab, to be marketed as Leqembi, is likely to generate considerable interest from patients and physicians. Read more at straitstimes.com.
WASHINGTON - The US Food and Drug Administration on Friday approved a new Alzheimer’s drug that may modestly slow the pace of cognitive decline early in the disease but also carries risks of swelling and bleeding in the brain.
Eisai said the list price for Leqembi would be $26,500 per year. The price is slightly lower than Aduhelm’s but higher than that recommended by some analysts. In its decision, the FDA appeared to be acknowledging the vehement criticism that erupted when it approved Aduhelm in 2021 after both a committee of independent advisers and an FDA council of senior officials said there was not enough evidence that it worked.
The Leqembi label says the drug should be used only for patients in early and mild stages of Alzheimer’s disease, matching the status of patients in the clinical trials of the drug. It instructs doctors not to treat patients without doing tests to confirm that they have one of the hallmarks of Alzheimer’s: a buildup of the protein amyloid, which Leqembi attacks.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Treat all our guests fairly: Sin Chew DailyThe paper says countries should view China’s reopening with cautious optimism. Read more at straitstimes.com.
続きを読む »
Sky High: 7 luxurious hotel penthouses to live it up in 2023Looking to treat yourself this year? Book one of these penthouses to match your travel mood.
続きを読む »
Graphite Bio pauses early-stage blood disease therapy trialGene therapy firm Graphite Bio said on Thursday it was pausing an early-to-mid-stage trial of its blood disease therapy due to a serious adverse event in the first patient dosed, sending its shares down nearly 48 per cent in after hours trading. After being given Graphite's therapy, nula-cel, the patient
続きを読む »
Too early for trophy talk, says Man Utd boss Ten HagManchester United manager Erik Ten Hag said his team are in a 'good position' but it was still too early for them to be thinking about silverware, ahead of an FA Cup tie against Everton.United will be looking for their seventh straight win in all competitions when they face a struggling Everton side on Fr
続きを読む »
Look Ahead 2023: Economic uncertainty and inflation lower chances of an early General Election, risk deepening social divides, say analystsSINGAPORE — With the rising cost of living amid an uncertain global economic outlook hitting middle-income earners, and the recent Goods and Services Tax (GST) hike viewed by some as a contributing factor, analysts say the low likelihood of an early General Election (GE) being called in 2023 has become more remote.
続きを読む »
Bayern Munich sign Dutch defender BlindBayern Munich have signed Dutch defender Daley Blind on a free transfer on a six-month contract, the Bundesliga club said on Thursday. The 32-year-old became a free agent last week after agreeing to terminate his contract with Ajax Amsterdam six months early. 'We are really pleased that Daley has
続きを読む »